Epstein-Barr Virus-Induced Gene 3 (EBI3) Blocking Leads to Induce Antitumor Cytotoxic T Lymphocyte Response and Suppress Tumor Growth in Colorectal Cancer by Bidirectional Reciprocal-Regulation STAT3 Signaling Pathway

Epstein-Barr virus-induced gene 3 (EBI3) is a member of the interleukin-12 (IL-12) family structural subunit and can form a heterodimer with IL-27p28 and IL-12p35 subunit to build IL-27 and IL-35, respectively. However, IL-27 stimulates whereas IL-35 inhibits antitumor T cell responses. To date, lit...

Full description

Saved in:
Bibliographic Details
Main Authors: Yanfang Liang, Qianqian Chen, Wenjing Du, Can Chen, Feifei Li, Jingying Yang, Jianyu Peng, Dongping Kang, Bihua Lin, Xingxing Chai, Keyuan Zhou, Jincheng Zeng
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2016/3214105
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549235016335360
author Yanfang Liang
Qianqian Chen
Wenjing Du
Can Chen
Feifei Li
Jingying Yang
Jianyu Peng
Dongping Kang
Bihua Lin
Xingxing Chai
Keyuan Zhou
Jincheng Zeng
author_facet Yanfang Liang
Qianqian Chen
Wenjing Du
Can Chen
Feifei Li
Jingying Yang
Jianyu Peng
Dongping Kang
Bihua Lin
Xingxing Chai
Keyuan Zhou
Jincheng Zeng
author_sort Yanfang Liang
collection DOAJ
description Epstein-Barr virus-induced gene 3 (EBI3) is a member of the interleukin-12 (IL-12) family structural subunit and can form a heterodimer with IL-27p28 and IL-12p35 subunit to build IL-27 and IL-35, respectively. However, IL-27 stimulates whereas IL-35 inhibits antitumor T cell responses. To date, little is known about the role of EBI3 in tumor microenvironment. In this study, firstly we assessed EBI3, IL-27p28, IL-12p35, gp130, and p-STAT3 expression with clinicopathological parameters of colorectal cancer (CRC) tissues; then we evaluated the antitumor T cell responses and tumor growth with a EBI3 blocking peptide. We found that elevated EBI3 may be associated with IL-12p35, gp130, and p-STAT3 to promote CRC progression. EBI3 blocking peptide promoted antitumor cytotoxic T lymphocyte (CTL) response by inducing Granzyme B, IFN-γ production, and p-STAT3 expression and inhibited CRC cell proliferation and tumor growth to associate with suppressing gp130 and p-STAT3 expression. Taken together, these results suggest that EBI3 may mediate a bidirectional reciprocal-regulation STAT3 signaling pathway to assist the tumor escape immune surveillance in CRC.
format Article
id doaj-art-69a1ad78397b4ad78a962343804885b8
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-69a1ad78397b4ad78a962343804885b82025-02-03T06:11:43ZengWileyMediators of Inflammation0962-93511466-18612016-01-01201610.1155/2016/32141053214105Epstein-Barr Virus-Induced Gene 3 (EBI3) Blocking Leads to Induce Antitumor Cytotoxic T Lymphocyte Response and Suppress Tumor Growth in Colorectal Cancer by Bidirectional Reciprocal-Regulation STAT3 Signaling PathwayYanfang Liang0Qianqian Chen1Wenjing Du2Can Chen3Feifei Li4Jingying Yang5Jianyu Peng6Dongping Kang7Bihua Lin8Xingxing Chai9Keyuan Zhou10Jincheng Zeng11Department of Pathology, Dongguan Hospital, Medical College of Jinan University, The Fifth People’s Hospital of Dongguan, Dongguan 523905, ChinaGuangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan 523808, ChinaDepartment of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai 200040, ChinaDepartment of Pathology, Dongguan Hospital, Medical College of Jinan University, The Fifth People’s Hospital of Dongguan, Dongguan 523905, ChinaGuangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan 523808, ChinaGuangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan 523808, ChinaGuangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan 523808, ChinaDepartment of Pathology, Dongguan Hospital, Medical College of Jinan University, The Fifth People’s Hospital of Dongguan, Dongguan 523905, ChinaGuangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan 523808, ChinaGuangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan 523808, ChinaGuangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan 523808, ChinaGuangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan 523808, ChinaEpstein-Barr virus-induced gene 3 (EBI3) is a member of the interleukin-12 (IL-12) family structural subunit and can form a heterodimer with IL-27p28 and IL-12p35 subunit to build IL-27 and IL-35, respectively. However, IL-27 stimulates whereas IL-35 inhibits antitumor T cell responses. To date, little is known about the role of EBI3 in tumor microenvironment. In this study, firstly we assessed EBI3, IL-27p28, IL-12p35, gp130, and p-STAT3 expression with clinicopathological parameters of colorectal cancer (CRC) tissues; then we evaluated the antitumor T cell responses and tumor growth with a EBI3 blocking peptide. We found that elevated EBI3 may be associated with IL-12p35, gp130, and p-STAT3 to promote CRC progression. EBI3 blocking peptide promoted antitumor cytotoxic T lymphocyte (CTL) response by inducing Granzyme B, IFN-γ production, and p-STAT3 expression and inhibited CRC cell proliferation and tumor growth to associate with suppressing gp130 and p-STAT3 expression. Taken together, these results suggest that EBI3 may mediate a bidirectional reciprocal-regulation STAT3 signaling pathway to assist the tumor escape immune surveillance in CRC.http://dx.doi.org/10.1155/2016/3214105
spellingShingle Yanfang Liang
Qianqian Chen
Wenjing Du
Can Chen
Feifei Li
Jingying Yang
Jianyu Peng
Dongping Kang
Bihua Lin
Xingxing Chai
Keyuan Zhou
Jincheng Zeng
Epstein-Barr Virus-Induced Gene 3 (EBI3) Blocking Leads to Induce Antitumor Cytotoxic T Lymphocyte Response and Suppress Tumor Growth in Colorectal Cancer by Bidirectional Reciprocal-Regulation STAT3 Signaling Pathway
Mediators of Inflammation
title Epstein-Barr Virus-Induced Gene 3 (EBI3) Blocking Leads to Induce Antitumor Cytotoxic T Lymphocyte Response and Suppress Tumor Growth in Colorectal Cancer by Bidirectional Reciprocal-Regulation STAT3 Signaling Pathway
title_full Epstein-Barr Virus-Induced Gene 3 (EBI3) Blocking Leads to Induce Antitumor Cytotoxic T Lymphocyte Response and Suppress Tumor Growth in Colorectal Cancer by Bidirectional Reciprocal-Regulation STAT3 Signaling Pathway
title_fullStr Epstein-Barr Virus-Induced Gene 3 (EBI3) Blocking Leads to Induce Antitumor Cytotoxic T Lymphocyte Response and Suppress Tumor Growth in Colorectal Cancer by Bidirectional Reciprocal-Regulation STAT3 Signaling Pathway
title_full_unstemmed Epstein-Barr Virus-Induced Gene 3 (EBI3) Blocking Leads to Induce Antitumor Cytotoxic T Lymphocyte Response and Suppress Tumor Growth in Colorectal Cancer by Bidirectional Reciprocal-Regulation STAT3 Signaling Pathway
title_short Epstein-Barr Virus-Induced Gene 3 (EBI3) Blocking Leads to Induce Antitumor Cytotoxic T Lymphocyte Response and Suppress Tumor Growth in Colorectal Cancer by Bidirectional Reciprocal-Regulation STAT3 Signaling Pathway
title_sort epstein barr virus induced gene 3 ebi3 blocking leads to induce antitumor cytotoxic t lymphocyte response and suppress tumor growth in colorectal cancer by bidirectional reciprocal regulation stat3 signaling pathway
url http://dx.doi.org/10.1155/2016/3214105
work_keys_str_mv AT yanfangliang epsteinbarrvirusinducedgene3ebi3blockingleadstoinduceantitumorcytotoxictlymphocyteresponseandsuppresstumorgrowthincolorectalcancerbybidirectionalreciprocalregulationstat3signalingpathway
AT qianqianchen epsteinbarrvirusinducedgene3ebi3blockingleadstoinduceantitumorcytotoxictlymphocyteresponseandsuppresstumorgrowthincolorectalcancerbybidirectionalreciprocalregulationstat3signalingpathway
AT wenjingdu epsteinbarrvirusinducedgene3ebi3blockingleadstoinduceantitumorcytotoxictlymphocyteresponseandsuppresstumorgrowthincolorectalcancerbybidirectionalreciprocalregulationstat3signalingpathway
AT canchen epsteinbarrvirusinducedgene3ebi3blockingleadstoinduceantitumorcytotoxictlymphocyteresponseandsuppresstumorgrowthincolorectalcancerbybidirectionalreciprocalregulationstat3signalingpathway
AT feifeili epsteinbarrvirusinducedgene3ebi3blockingleadstoinduceantitumorcytotoxictlymphocyteresponseandsuppresstumorgrowthincolorectalcancerbybidirectionalreciprocalregulationstat3signalingpathway
AT jingyingyang epsteinbarrvirusinducedgene3ebi3blockingleadstoinduceantitumorcytotoxictlymphocyteresponseandsuppresstumorgrowthincolorectalcancerbybidirectionalreciprocalregulationstat3signalingpathway
AT jianyupeng epsteinbarrvirusinducedgene3ebi3blockingleadstoinduceantitumorcytotoxictlymphocyteresponseandsuppresstumorgrowthincolorectalcancerbybidirectionalreciprocalregulationstat3signalingpathway
AT dongpingkang epsteinbarrvirusinducedgene3ebi3blockingleadstoinduceantitumorcytotoxictlymphocyteresponseandsuppresstumorgrowthincolorectalcancerbybidirectionalreciprocalregulationstat3signalingpathway
AT bihualin epsteinbarrvirusinducedgene3ebi3blockingleadstoinduceantitumorcytotoxictlymphocyteresponseandsuppresstumorgrowthincolorectalcancerbybidirectionalreciprocalregulationstat3signalingpathway
AT xingxingchai epsteinbarrvirusinducedgene3ebi3blockingleadstoinduceantitumorcytotoxictlymphocyteresponseandsuppresstumorgrowthincolorectalcancerbybidirectionalreciprocalregulationstat3signalingpathway
AT keyuanzhou epsteinbarrvirusinducedgene3ebi3blockingleadstoinduceantitumorcytotoxictlymphocyteresponseandsuppresstumorgrowthincolorectalcancerbybidirectionalreciprocalregulationstat3signalingpathway
AT jinchengzeng epsteinbarrvirusinducedgene3ebi3blockingleadstoinduceantitumorcytotoxictlymphocyteresponseandsuppresstumorgrowthincolorectalcancerbybidirectionalreciprocalregulationstat3signalingpathway